It has been reported that SGLT2 is present in retinal pericytes and mesangial cells, and it has been reported that SGLT2 inhibitors may protect diabetic retinopathy through direct actions on the retinal pericytes [14]. This evidence concerns the gene SLC5A2 and diabetic retinopathy.